WHO ICTRP trial
Clinical evaluation of Tiaochang Xiaoyan tablet combined with Shenling Baizhu…
ChiCTR2300078596 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300078596 |
|---|---|
| Public title | Clinical evaluation of Tiaochang Xiaoyan tablet combined with Shenling Baizhu San capsule in the treatment of moderate and severe active ulcerative colitis |
| Scientific title | Clinical evaluation of Tiaochang Xiaoyan tablet combined with Shenling Baizhu San capsule in the treatment of moderate and severe active ulcerative colitis |
| Primary sponsor | Guangdong Provincial Hospital of Chinese medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Ulcerative colitis |
| Interventions | control group:Placebo: receive placebo of Tiaochang Xiaoyan tablet (4 tablets per time, 4 times a day) and Shenlingbaizhu San capsule placebo (3 tablets each time, 3 times a day, orally) for 12 weeks, once every 2 weeks; follow-up for 36… |
| Registration date | Dec 13, 2023 |
| Target size | control group:10;Intervention group:10 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: